Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |